slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
217,561-217,620 of 319,975
24
Includes a map of Turkey, a bar chart comparing gaming spend as % of GDP, and two bar charts showing growth in turnover and online stake penetration.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
Includes Sustainalytics ranking as a validation metric.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
26
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
27
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
28
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
01
Includes company logo, tagline, and date.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
02
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
03
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a three-column layout to highlight key value propositions of the Olvi-Vec technology.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to show clinical trial stages for multiple drug candidates.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
Uses a process diagram to illustrate the transition from cold to hot tumor states via viral infection.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The central diagram shows a biological mechanism comparing 'Absence of Effector T Cells' (Platinum resistant) vs 'Presence of Effector T Cells' (Platinum sensitive).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
The slide uses a timeline to establish market maturity and investor confidence.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a list-based comparison and a logo-grid to frame the competitive landscape.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a pyramid diagram to represent the evolution of oncolytic virus technology, with Genelux's platform at the top.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a document-style callout for key takeaways and a vertical icon-list for clinical data points.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide uses a process-flow layout to show the trial design and its validation through publications and follow-up trials.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
Data table presents ORR, Duration of Response, CA-125 response, PFS, and OS across patient subgroups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
Waterfall plot and spider plot showing patient-level clinical outcomes.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a series of bar charts to compare PFS across multiple treatment regimens for three specific patients (15B-01, 15B-15, 15B-17).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
Kaplan-Meier survival curve showing superior performance of VIRO-15 compared to historical 4th line treatment data.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
The chart compares cross-trial data; the footnote explicitly warns against direct comparison due to protocol differences.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) as evidence of efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
Includes a bio for Benny Li, PhD, CEO of Newsoara.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide highlights a strategic partnership, funding, and commercial rights split between US and Greater China markets.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide highlights a combination therapy approach involving oncolytic immunotherapy and adoptive cell therapy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a map of the US as a background to anchor the market sizing to a specific geography.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
25
The slide highlights physical assets and operational capacity.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
26
The slide uses a hub-and-spoke style layout to show the four pillars supporting the central launch strategy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
27
The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies, emphasizing non-GMO status and GLP tox readiness.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
The slide highlights key defensive moats including patent counts, expiration dates, and lack of royalty obligations.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
29
The slide uses a grid layout to categorize team members into three distinct groups: Executive Team, Board of Directors, and Operations & R&D.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
30
The slide uses a combination of a checklist for past achievements and a timeline arrow for future goals.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
31
Includes footnotes regarding market close date and specific financing obligations.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
32
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
33
The slide indicates this is an appendix section of an October 2023 corporate presentation.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
34
The slide lists key advisors, some of whom also hold executive roles (CEO, CMO, CFO) within the company.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
Includes microscopic imagery of patient samples (Pt.#15A-01 and Pt.#15A-11) showing longitudinal progression of treatment.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
The slide compares pre- and post-treatment biopsies for three patients (15A-16, 15A-18, 15A-23) using both visual microscopy and quantitative infiltration histograms.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a combination of a bar chart (ELISPOT data) and a line chart (SLD over time) to show clinical efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
38
The slide uses clinical study data (VIRO-15, NCT01443260) to support its claims.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
Includes list of geographic locations and KBW branding.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
02
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
03
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
04
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
05
Includes a map of US branches and LPOs, and a sidebar of financial KPIs.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Problem1 hit
06
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Problem1 hit
07
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Problem1 hit
08
The slide uses a 2x2 quadrant layout to organize key performance metrics and strategic highlights.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Problem1 hit
09
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
10
The slide includes detailed footnotes regarding specific loan categories.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
11
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
12
Uses a bridge-style donut chart comparison to show portfolio evolution over a decade.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
13
Includes detailed footnotes explaining loan classifications and calculation methodologies.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
14
The slide uses two donut charts to visualize the composition of two distinct loan portfolios.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
15
The slide uses donut charts to visualize the geographical concentration of different CRE loan categories.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
16
The slide presents three distinct tables summarizing financial data for different loan categories.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
17
The table includes a footnote regarding C&I lines of credit and rounding.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit